Allergy Therapeutics's market cap is currently £395.61M. The company's EPS TTM is p-0.002; its P/E ratio is ―; Allergy Therapeutics is scheduled to report earnings on March 31, 2025, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
